Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -2.52%. However, over the past six months, we’ve seen a stronger performance of -9.92%. The price of EW leaped by -5.34% over the last 30 days. And in the last five days, it has fallen by -2.86%.
Currently, the stock price of Edwards Lifesciences Corporation (EW) is $72.73. In the most recent trading session, the stock underwent a significant upswing, peaking at $74.53 after opening at $73.88. The stock touched a low of $73.13 before closing at $73.20.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Edwards Lifesciences Corporation had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $94.87 on 06/30/23, while the lowest price during the same period was $67.13 on 11/08/22.
52-week price history of EW Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Edwards Lifesciences Corporation’s current trading price is -23.34% away from its 52-week high, while its distance from the 52-week low is 8.34%. The stock’s price range over this timeframe has been between $67.13 and $94.87. The shares of the Healthcare sector company recorded a trading volume of approximately 2.13 million for the day, which was comparatively lower than the average daily volume of 3.21 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Edwards Lifesciences Corporation (EW) has experienced a quarterly decline of -20.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 44.71B and boasts a workforce of 17300 employees.
Expert Opinions: Analysts’ Ratings for Edwards Lifesciences Corporation
As of right now, 13 analysts are rating Edwards Lifesciences Corporation as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 14 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 84.64, with a change in price of -15.47. Similarly, Edwards Lifesciences Corporation recorded 2,964,553 in trading volume during the last 100 days, posting a change of -17.63%.
EW’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for EW stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.09.
EW Stock Stochastic Average
The raw stochastic average for Edwards Lifesciences Corporation over the last 50 days is presently at 2.22%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 7.33%. Further, the company’s Stochastic %K and %D values for the last 20 days were 11.92% and 11.17%, respectively.
